Search
Edwards Lifesciences Corp
EWAdd to Watchlist
89.920USD
+0.140+0.16%
Close 09-04 16:00（ET）
51.84BMarket Cap
47.74P/E TTM
Revenue Breakdown
Currency: USDUpdated: Fri, Aug 28
Currency: USDUpdated: Fri, Aug 28
FY2026Q2
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
By BusinessUSD
Name
Revenue
Proportion
Transcatheter Aortic Valve Replacement
1.26B
72.27%
Surgical Heart Valve Therapy
284.10M
16.32%
Transcatheter Mitral and Tricuspid Therapies
198.60M
11.41%
By RegionUSD
Name
Revenue
Proportion
United States
1.00B
57.64%
Europe
439.60M
25.25%
Rest of the world
201.50M
11.57%
Japan
96.40M
5.54%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Transcatheter Aortic Valve Replacement
1.26B
72.27%
Surgical Heart Valve Therapy
284.10M
16.32%
Transcatheter Mitral and Tricuspid Therapies
198.60M
11.41%